EUVIMEDEUVIMED entdecken
Crossref

Effect of Individualised Homeopathic Medicine as Adjunct to Fluticasone Furoate for Allergic Rhinitis: A Prospective, Randomised, Open-Label, Controlled Trial

Ashish Kumar Dixit iD, Anjan Kumar Sahoo, Shaila Sidam, Nibha Giri

Homeopathy · 12.12.2025

DOI: 10.1055/a-2687-9635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Homeopathy, erschienen am 12.12.2025. Verfasst von Ashish Kumar Dixit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of AYUSH, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic rhinitis (AR) impairs quality of life, with intranasal corticosteroids like fluticasone furoate as standard of care (SOC). Individualised homeopathic medicines (IHMs) are increasingly used as adjuncts, but robust evidence is limited. This study evaluates whether an IHM combined with SOC improves clinical outcomes compared with SOC alone in moderate to severe AR. In a randomized, open-label, controlled trial, 210 adults with AR (Total Nasal Symptom Score [TNSS] ≥ 6) were assigned 1:1 to SOC or SOC + IHM for a 12-week treatment phase, followed by a 6-week observational follow-up phase. Primary outcome was TNSS; secondary outcomes included Mini Rhinoconjunctivitis Quality of Life Questionnaire (Mini-RQLQ) and Visual Analogue Scale (VAS). Outcomes were assessed at baseline, 4, 12 and 18 weeks using repeated-measures analysis of variance (RM-ANOVA) and t-tests in an intention-to-treat analysis. Both groups showed significant within-group TNSS reductions at 4 and 12 weeks (all p < 0.001), with no between-group differences (p > 0.99). At 18 weeks, when no treatment was administered, SOC + IHM had lower TNSS (1.44 ± 1.00) than SOC (6.48 ± 1.71, p < 0.001), with similar trends for Mini-RQLQ (0.88 ± 0.31 vs. 2.24 ± 0.42, p < 0.001) and VAS (2.04 ± 0.84 vs. 6.35 ± 1.38, p < 0.001). RM-ANOVA showed no Group × Time interaction at 12 weeks (TNSS: p = 0.146, partial η2 = 0.009), but significant interactions at 18 weeks (TNSS: p < 0.001, partial η2 = 0.738). Dropout was minimal (

Autor:innen und Institutionen

  • Department of AYUSH, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
  • Department of Otorhinolaryngology (ENT)-Head & Neck Surgery, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
  • Department of Homeopathy, State Homeopathic Dispensary, Jakhanian, Ghazipur, Uttar Pradesh, India.

ORCID-Profile: Ashish Kumar Dixit

Zitieren

APA

Dixit, A. K., Sahoo, A. K., Sidam, S., & Giri, N. (2025). Effect of Individualised Homeopathic Medicine as Adjunct to Fluticasone Furoate for Allergic Rhinitis: A Prospective, Randomised, Open-Label, Controlled Trial. Homeopathy. https://doi.org/10.1055/a-2687-9635

Vancouver

Dixit AK, Sahoo AK, Sidam S, Giri N. Effect of Individualised Homeopathic Medicine as Adjunct to Fluticasone Furoate for Allergic Rhinitis: A Prospective, Randomised, Open-Label, Controlled Trial. Homeopathy. 2025. doi:10.1055/a-2687-9635

BibTeX
@article{Dixit2025,
  author = {Dixit, Ashish Kumar and Sahoo, Anjan Kumar and Sidam, Shaila and Giri, Nibha},
  title = {Effect of Individualised Homeopathic Medicine as Adjunct to Fluticasone Furoate for Allergic Rhinitis: A Prospective, Randomised, Open-Label, Controlled Trial},
  journal = {Homeopathy},
  year = {2025},
  doi = {10.1055/a-2687-9635}
}
Kostenlos starten →